The silver economy shines for long term growth in portfolios

Global Biotechnology identified by Insync as a megatrends

Insync increase exposure to global healthcare

Why the world’s most profitable beer company should be part of your portfolio

The pharmaceutical sector continues to be under appreciated

Biologics and biosimilar explained